Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  28 (2024)
Volume  27 (2023)
Volume  26 (2022)
Volume  25 (2021)
Volume  24 (2020)
Volume  23 (2019)
Volume  22 (2018)
Volume  21 (2017)
Volume  20 (2016)
Volume  19 (2015)
Volume  18 (2014)
Volume  17 (2013)
Volume  16 (2012)
Volume  15 (2011)
Volume  14 (2010)
Volume  13 (2009)
Volume  12 (2008)
Volume  11 (2007)
Volume  10 (2006)
Volume  9 (2005)
Volume  8 (2004)
Related articles

VOLUME 25 , ISSUE 4 ( April, 2021 ) > List of Articles

LETTER TO EDITOR

Second-degree Heart Block Caused by Itolizumab-induced Infusion Reaction in COVID-19

Dharani Lenin, Shaheen Ahmad

Citation Information : Lenin D, Ahmad S. Second-degree Heart Block Caused by Itolizumab-induced Infusion Reaction in COVID-19. Indian J Crit Care Med 2021; 25 (4):474-475.

DOI: 10.5005/jp-journals-10071-23794

License: CC BY-NC 4.0

Published Online: 01-04-2021

Copyright Statement:  Copyright © 2021; The Author(s).


Abstract
HTML PDF Share
  1. Nair P, Melarkode R, Rajkumar D, Montero E. CD6 synergistic co-stimulation promoting proinflammatory response is modulated without interfering with the activated leucocyte cell adhesion molecule interaction. Clin Exp Immunol 2010;162(1):116–130. DOI: 10.1111/j.1365-2249.2010.04235.x.
  2. Ministry of Health and Family Welfare, India. DCGI gives Nod for restricted emergency use to Itolizumab for moderate to severe COVID-19 patients. Press release. Available from: https://pib.gov.in/PressReleasePage.aspx?PRID=1637926. Accessed 22 December 2020.
  3. Lenz HJ. Management and preparedness for infusion and hypersensitivity reactions. Oncologist 2007;12(5):601–609. DOI: 10.1634/theoncologist.12-5-601.
  4. Vogel WH. Infusion reactions: diagnosis, assessment, and management. Clin J Oncol Nurs 2010;14(2):E10–E21. DOI: 10.1188/10.CJON.E10-E21.
  5. Poterucha JT, Westberg M, Nerheim P, Lovell JP. Rituximab-induced polymorphic ventricular tachycardia. Tex Heart Inst J 2010;37(2):218–220. PMID: 20401299. PMCID: PMC2851419.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.